You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 97 No. 10, October 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Dipivefrin and Echothiophate

Contraindications to Combined Use

Idida Abramovsky, MD; Joel S. Mindel, MD, PhD

Arch Ophthalmol. 1979;97(10):1937-1940.


Abstract

• A study was undertaken to determine whether the antiesterase activity of echothiophate iodide would prevent the conversion of dipivefrin to epinephrine. Dipivefrin was administered singly and in combination with echothiophate to 24 adult rabbits. Administration of dipivefrin lowered the intraocular pressure (IOP) 8 ± 1 mm Hg (P <.001). When echothiophate was given before and concomitant with dipivefrin, there was no further decrease in IOP compared with that produced by echothiophate alone (5 ± 1 mm Hg). Addition of epinephrine to eyes receiving dipivefrin plus echothiophate resulted in a significant additional decrease in IOP of 4 ± 1 mm Hg (P <.001). When echothiophate was given after dipivefrin had lowered the IOP and both drugs were continued, the IOP rose to baseline levels. These results fit the theory that the esterase converting dipivefrin to epinephrine is inactivated by cholinesterase inhibitors. The clinical use of cholinesterase inhibitors and dipivefrin may be contraindicated.



Author Affiliations

From the Departments of Ophthalmology (Drs Abramovsky and Mindel) and Pharmacology (Dr Mindel), Mount Sinai School of Medicine, New York, and Bronx Veterans Administration Hospital, New York (Dr Mindel).


Footnotes

Accepted for publication Feb 13, 1979.

Reprint requests to Mount Sinai Hospital, Annenberg Bldg 22-14, 1 Gustave L. Levy Pl, New York, NY 10029 (Dr Mindel).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effects of Echothiophate on Enzymatic Hydrolysis of Dipivefrin
Anderson et al.
Arch Ophthalmol 1984;102:913-916.
ABSTRACT  

Enzymatic and Nonenzymatic Hydrolysis of D,L-Dipivefrin
Mindel et al.
Arch Ophthalmol 1984;102:457-460.
ABSTRACT  

The Effect of Echothiophate on the Biphasic Response of Rabbit Ocular Pressure to Dipivefrin
Mindel et al.
Arch Ophthalmol 1982;100:147-151.
ABSTRACT  

Dipivefrin and Echothiophate: Efficacy of Combined Use in Human Beings
Mindel et al.
Arch Ophthalmol 1981;99:1583-1586.
ABSTRACT  

Is Phenylephrine Pivalate a Prodrug?
Mindel et al.
Arch Ophthalmol 1980;98:2220-2223.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.